Comparative Evaluation of 2 Nucleic Acid Amplification Tests for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae at Extragenital Sites
- 1 July 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 44 (7) , 398-400
Abstract
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are frequently asymptomatic, requiring highly accurate diagnostic tests and proper management to prevent further transmission. We compared two nucleic acid tests, Xpert® CT/NG (Cepheid, Sunnyvale, CA) point-of-care platform and at an offsite clinical laboratory with Aptima Combo 2® (Hologic, Inc., San Diego, CA) assay, for the detection of extragenital infection in patients at an STI clinic in Hollywood, CA. We calculated concordance between the two assays and used the exact binomial method to calculate 95% confidence intervals (CIs) for each specimen type and pathogen. The concordance between the two assays was 97.7% (95% CI: 95.7%,99.0%) for 393 paired CT rectal results, 98.2% (95% CI: 96.4%,99.3%) for 391 paired NG rectal results and 98.4% (95% CI: 96.8%,99.4%) for 448 paired NG pharyngeal results. The performance of Xpert® CT/NG assay in point-of-care testing in extragenital specimens was highly similar to the laboratory-based platform.Keywords
This publication has 18 references indexed in Scilit:
- Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global ReportingPLOS ONE, 2015
- Evidence for Increased Chlamydia Case Finding After the Introduction of Rectal Screening Among Women Attending 2 Canadian Sexually Transmitted Infection ClinicsClinical Infectious Diseases, 2014
- Characteristics of the Sample Adequacy Control (SAC) in the Cepheid Xpert® CT/NG Assay in Female Urine SpecimensJournal of Microbiology & Experimentation, 2014
- Extragenital Gonorrhea and Chlamydia Testing and Infection Among Men Who Have Sex With Men--STD Surveillance Network, United States, 2010-2012Clinical Infectious Diseases, 2014
- Review of use of a new rapid real-time PCR, the Cepheid GeneXpert®(Xpert) CT/NG assay, forChlamydia trachomatisandNeisseria gonorrhoeae: results for patients while in a clinical settingExpert Review of Molecular Diagnostics, 2014
- Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeaeJournal of Clinical Microbiology, 2013
- Comparison of the Abbott m 2000 RealTi m e CT Assay and the Cepheid GeneXpert CT/NG Assay to the Roche Amplicor CT Assay for Detection of Chlamydia trachomatis in Ocular Samples from TanzaniaJournal of Clinical Microbiology, 2013
- Performance of the GeneXpert CT/NG Assay Compared to That of the Aptima AC2 Assay for Detection of Rectal Chlamydia trachomatis and Neisseria gonorrhoeae by Use of Residual Aptima SamplesJournal of Clinical Microbiology, 2012
- Comparison of Three Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis in Urine SpecimensJournal of Clinical Microbiology, 2004
- Head-to-Head Multicenter Comparison of DNA Probe and Nucleic Acid Amplification Tests for Chlamydia trachomatis Infection in Women Performed with an Improved Reference StandardJournal of Clinical Microbiology, 2002